Table 3.
Results of mycological cultures of samples from the AmarCAND2 patients, according to their status at SAT initiation: invasive candidiasis either proven, or suspected
| SAT for proven invasive candidiasis N = 291 |
SAT for suspected invasive candidiasis N = 544 |
Overall population N = 835 |
|
|---|---|---|---|
| Patients with at least an isolate identified, i.e., proven IC | 291 (100) | 112 (20.6) | 403 (48.3 %) |
| Number of identified isolates | 325 | 128 | 453 |
| C. albicans | 206 (63.4) | 90 (70.3) | 296 (65.3) |
| C. glabrata | 54 (16.6) | 18 (14.0) | 72 (15.9) |
| C. parapsilosis | 19 (5.8) | 2 (1.6) | 21 (4.6) |
| C. tropicalis | 14 (4.3) | 6 (4.7) | 20 (4.4) |
| C. krusei | 10 | 3 | 13 |
| C. lusitaniae | 9 | 1 | 10 |
| C. kefyr | 6 | 2 | 8 |
| C. guilliermondii | 3 | 1 | 4 |
| C. dubliniensis | 2 | 0 | 2 |
| C. norvengiensis | 1 | 1 | 2 |
| C. pulcherina | 1 | 0 | 1 |
| Other | 0 | 4 | 4 |
The results are given as n (%)
SAT systemic antifungal therapy, IC invasive candidiasis